BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 41426)

  • 1. Regulation of Leishmania populations within the host. IV. Parasite and host cell kinetics studied by radioisotope labelling.
    Bradley DJ
    Acta Trop; 1979 Jun; 36(2):171-9. PubMed ID: 41426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice.
    Bradley DJ; Kirkley J
    Clin Exp Immunol; 1977 Oct; 30(1):119-29. PubMed ID: 606433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG; Lima GC; Engers HD; Louis JA
    J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The scavenger receptor MARCO is involved in Leishmania major infection by CBA/J macrophages.
    Gomes IN; Palma LC; Campos GO; Lima JG; DE Almeida TF; DE Menezes JP; Ferreira CA; Santos RR; Buck GA; Manque PA; Ozaki LS; Probst CM; DE Freitas LA; Krieger MA; Veras PS
    Parasite Immunol; 2009 Apr; 31(4):188-98. PubMed ID: 19292770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection.
    Bradley DJ
    Clin Exp Immunol; 1977 Oct; 30(1):130-40. PubMed ID: 606434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro.
    Hockmeyer WT; Walters D; Gore RW; Williams JS; Fortier AH; Nacy CA
    J Immunol; 1984 Jun; 132(6):3120-5. PubMed ID: 6725948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
    Belosevic M; Finbloom DS; Van Der Meide PH; Slayter MV; Nacy CA
    J Immunol; 1989 Jul; 143(1):266-74. PubMed ID: 2499629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cells at the host-pathogen interface: host-protection versus immune evasion in leishmaniasis.
    Saha B; Tonkal AM; Croft S; Roy S
    Clin Exp Immunol; 2004 Jul; 137(1):19-23. PubMed ID: 15196239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful vaccination against Leishmania chagasi infection in BALB/c mice with freeze-thawed Leishmania antigen and Corynebacterium parvum.
    Vilela Mde C; Gomes DC; Marques-da-Silva Ede A; Serafim TD; Afonso LC; Rezende SA
    Acta Trop; 2007; 104(2-3):133-9. PubMed ID: 17919443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Leishmania donovani reproduction during chronic infections in mice.
    Bradley DJ
    Trans R Soc Trop Med Hyg; 1971; 65(1):17-8. PubMed ID: 5092414
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H; Hockertz S
    Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the host response to Leishmania mexicana.
    Pérez H
    Ciba Found Symp; 1983; 99():157-73. PubMed ID: 6227462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
    Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
    Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological responses of L. donovani infection in mice and significance of T cell in resistance to experimental leishmaniasis.
    Rezai HR; Farrell J; Soulsby EL
    Clin Exp Immunol; 1980 Jun; 40(3):508-14. PubMed ID: 6968259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of variables associated with promotion of resistance and its abrogation in T cell-reconstituted nude mice infected with Leishmania major.
    Moll H; Mitchell GF
    J Parasitol; 1988 Dec; 74(6):993-8. PubMed ID: 3264023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma.
    Cillari E; Dieli M; Maltese E; Milano S; Salerno A; Liew FY
    J Immunol; 1989 Sep; 143(6):2001-5. PubMed ID: 2506273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected.
    Abreu-Silva AL; Calabrese KS; Cupolilo SM; Cardoso FO; Souza CS; Gonçalves da Costa SC
    Vet Parasitol; 2004 May; 121(3-4):179-87. PubMed ID: 15135858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
    Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a real-time polymerase chain reaction assay for the quantification of Leishmania species and the monitoring of systemic distribution of the pathogen.
    Tupperwar N; Vineeth V; Rath S; Vaidya T
    Diagn Microbiol Infect Dis; 2008 May; 61(1):23-30. PubMed ID: 18255247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.